• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Nephrology

Everolimus treatment effective for improving renal function in lung transplant patients

byKathleen LauandAlex Chan
March 4, 2021
in Nephrology, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Lung transplant patients showed improved renal function and reduced immunosuppressant dosage after twelve months of everolimus treatment.

2. Patients with chronic lung allograft dysfunction showed either sustained or worsened lung function depending on phenotype.

Evidence Rating Level: 2 (Good)

Following a lung transplant, two factors which reduce survival are graft failure and chronic lung allograft dysfunction (CLAD). CLAD is a substantial (> 20%) and persistent decline from baseline in measured forced expiratory volume in the first second (FEV1). CLAD can present as two phenotypes, bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS). Everolimus is a maintenance immunosuppressant recently introduced to lung transplant patients to prevent CLAD with its antiproliferative properties. Due to its antifibrotic effects, everolimus has been shown to slow progression of both BOS and RAS. However, use of everolimus and its impact on renal and pulmonary function as well as mortality in both CLAD and non-CLAD patients has yet to be compared beyond 6 months. In this retrospective trial, renal and lung function of 26 patients with lung transplants treated with and/or switched to everolimus were monitored for 12 months. 17 patients had CLAD (10 BOS, 7 RAS), and in all patients, reduction in immunosuppressant dosage (ISD) and all-cause mortality rate were tracked. Overall, patients experienced improvement in renal function (serum creatinine -17%, estimated glomerular filtration rate +24%) and stabilization in pulmonary function (FEV1 -0.5%, forced vital capacity (FVC) +0.05%). While RAS patients, which typically have a worse prognosis, underwent progressive functional loss, BOS patients experienced a gradual increase in FEV1 and FVC stability. When comparing functional trends between CLAD and nonCLAD patients, the only significant difference occurred in the 12th month; FEV1 and FVC increased progressively. This resulting significant FVC% change is most likely due to the ameliorative effects of everolimus on renal function as opposed to direct pulmonary benefit. Finally, with the introduction of everolimus, all patients also experienced a significant and persistent ISD reduction (mean 37.7% reduction from baseline). While by design, this observational study cannot determine causation,  these results demonstrated the functional trends of improving renal function and reduced ISD in both CAD and non-CAD patients with lung transplants after treatment with everolimus. Despite everolimus introduction, CLAD patients continued to show declining pulmonary function, with the worst trend in RAS and with BOS identified as an “early everolimus responsive phenotype.” Ultimately, further study through conducting randomized, controlled trials with larger sample sizes are needed to support these trends.

Click to read the study Therapeutic Advances in Chronic Diseases

Image: PD

RELATED REPORTS

Intravenous hydrocortisone may reduce risk of kidney failure in patients with sepsis

Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension

2 Minute Medicine Rewind June 2, 2025

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: lung transplantnephrologypulmonology
Previous Post

#VisualAbstract: Higher SARS-CoV-2 infection rate in pregnant patients

Next Post

Tocilizumab reduced COVID-19 disease related adverse health outcomes

RelatedReports

Being overweight and obese associated with increased incidence of chronic kidney disease
Emergency

Intravenous hydrocortisone may reduce risk of kidney failure in patients with sepsis

June 5, 2025
Multiple-electrode switching radiofrequency ablation may successfully treat lung tumors
Cardiology

Sotatercept reduces adverse event risk in high-risk pulmonary arterial hypertension

June 5, 2025
Weekly Rewinds

2 Minute Medicine Rewind June 2, 2025

June 3, 2025
Shared decision-making may be limited in PICU end-of-life discussions
Chronic Disease

Social isolation is a marker of increased mortality and cardiovascular risk in patients with chronic kidney disease

May 27, 2025
Next Post
Prescription of antibiotics for acute respiratory infections increasing

Tocilizumab reduced COVID-19 disease related adverse health outcomes

Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia

Type 1 spinal muscular atrophy improved with risdiplam

#VisualAbstract: Aromatase inhibitors superior to tamoxifen for  progression-free survival in HR⁺ advanced breast cancer

#VisualAbstract: Higher metastatic lymph node burden is associated with worse overall survival in Merkel cell carcinoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Repeated medial branch blocks do not improve pain outcomes for thermal radiofrequency ablation
  • Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients
  • Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.